As Alzheimer’s Awareness Month comes to an end, Florida State University researchers are continuing efforts to better ...

Semaglutide, the drug behind the blockbuster weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline in people with early-stage Alzheimer's, according to two large new studies.

Alzheimer’s disease steals memory, independence and, too often, life itself. Drugs can ease symptoms, but none halt the march ...

Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as ...

Alzheimer’s disease affects many people worldwide, and while it can be diagnosed, many receive the diagnosis too late. Due to ...

New research published in the journal Nature suggests that modest doses of lithium orotate may prevent or even reverse ...

Researchers at Brain Chemistry Labs, a state-of-the-art biology laboratory in Jackson, are studying the brains of dolphins in ...

Share on PinterestNovo Nordisk has announced the cessation of the Evoke trials, looking at whether GLP-1 drugs could help ...

Millions of people are living with Alzheimer's disease, a progressive, irreversible brain disorder that causes cognitive decline, confusion, memory loss, and many other symptoms. The Alzheimer's Assoc ...

Administering an amino acid used to treat high blood pressure also appears to reverse signs of dementia in mice.

In people at risk for Alzheimer’s disease, researchers linked minimal to moderate physical activity to a 3-to 7-year delay in cognitive symptoms.